Participation of Noradrenergic Pathways in the Expression of Opiate Withdrawal: Biochemical and Pharmacological Evidence
- 31 January 1997
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 21 (1) , 91-104
- https://doi.org/10.1016/0149-7634(95)00061-5
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Role of β-adrenoceptors in the expression of morphine withdrawal signsLife Sciences, 1994
- Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the ratLife Sciences, 1994
- In vivo monoamine release during naloxane-precipitated morphine withdrawalNeuroReport, 1993
- Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering μ-opioid receptor sensitivityLife Sciences, 1993
- A comparison of the inhibitory effects of clonidine and guanfacine on the behavioral and autonomic components of morphine withdrawal in ratsLife Sciences, 1984
- Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: Evidence for noradrenergic hyperactivityLife Sciences, 1984
- Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidineLife Sciences, 1984
- Changes in alpha2 adrenoreceptors in various areas of the rat brain after long-term administration of “mu” and “kappa” opiate agonistsLife Sciences, 1983
- Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in ratsEuropean Journal of Pharmacology, 1983
- Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: Pharmacological differentiation using microiontophoretic techniquesLife Sciences, 1976